C-aryl glucoside SGLT2 inhibitors and method
US6515117B2 · kind B2 · utility
181Cited by
1References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 2002 |
| Grant date | Feb 4, 2003 |
| Priority date | — |
| Expiry date | May 20, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/203
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An SGLT2 inhibiting compound is provided having the formula A method is also provided for treating diabetes and related diseases employing an SGLT2 inhibiting amount of the above compound alone or in combination with another antidiabetic agent or other therapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.